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Summary In the present paper attempts have been made to investigate suppressor cell activity in CML
patients in first and subsequent remissions in order to study the relationship between suppressor cell activity
and progression of the disease. For this purpose, the ability of Con A activated suppressor cells from
peripheral blood of CML patients in 1st, 2nd and 3rd remission to suppress PHA response of autologous
lymphocytes is investigated and compared with that of normal healthy donors. The ability of Con A activated
cell population to form rosettes with autologous RBCs (ARFC) is also investigated. The results indicate that
lymphocytes from CML patients in 1st (61.8+6.1%), 2nd (62.6+3.0%) and 3rd (55.3+4.8%) remissions
show significantly high suppressor cell activity than normal healthy donors (36.5+1.9%) when activated with
Con A. Similarly, generation of spontaneous suppressor cell activity was also higher in 1st (23.3+4.7%) and
2nd (25.3+4.2%) remission lymphocytes than controls (10.1+2.5%). In the 3rd remission however, the
spontaneous suppressor cell activity (14.5+3.2%) was comparable to controls. Thus it appears that a higher
suppressor cell precursor population is present in CML patients in remission. However, this could not be
correlated with the progression of the disease. CML patients in 1st remission also revealed an increased
percentage of ARFC which correlated with the suppressor cell function. The ARFC activity tested in a few
patients in subsequent remissions was comparable with controls although functional suppressor activity was
increased.
Recently, suppressor T lymphocytes have been
associated with reduced in vitro T cell functions in
several neoplastic diseases in humans such as
thymoma, multiple myeloma, Hodgkin's disease
and other malignancies (Broder & Waldmann,
1978; Naor, 1979; Yu et al., 1977; Hersh et al.,
1980). Concanavalin A (Con A) has been
extensively used as an in vitro stimulus for the
generation of suppressor cells and soluble
suppressor factors (Shou et al., 1976) to elucidate
the suppressor phenomenon in cancer (Catalona et
al., 1980; Toge et al., 1980; Uchida & Micksche,
1981; Shulof et al., 1980; Yu et al., 1977).
In our earlier studies we demonstrated that
lymphocytes from chronic myeloid leukaemia
(CML) patients in remission react to leukaemia-
associated antogens in vitro (Gangal et al., 1976,
1979; Khare et al., 1981). When a small group of
patients was followed up through 2nd and 3rd
cycles of relapse and remission, it was observed that
leukaemia associated in vitro immune reactivity was
negatively correlated with the progress of the
disease (Gangal et al., 1977). It was felt that the
possible progressive inability of lymphocytes from
CML patients to respond to leukaemia-associated
antigens as the disease advanced, could be due to
increased suppressor cell activity. Therefore, in the
present paper we have attempted to assess the
generation of suppressor cell activity by Con A in
the peripheral blood of CML patients in first and
subsequent remissions. Suppressor cell activity has
been tested by the ability of Con A activated
lymphocytes to inhibit PHA response of autologous
lymphocytes, in comparison with similarly treated
lymphocytes obtained from normal healthy
individuals.
It is know that Con A is capable of inducing
both helper and suppressor populations depending
upon the dose of mitogen used. Sakane et al. (1981,
1982) tried to separate these two populations on the
basis of their observation that activated suppressor
cells are capable of forming rosettes with
autologous RBCs while helpers are not. We have
also attempted enumeration of autorosette forming
cells (ARFC) from Con A activated peripheral
blood mononuclear cells of CML patients in
remission and healthy donors, and compared the
percentages ofARFC with suppressor cell activity.
Materials and methods
CML patients
CML patients were diagnosed on the basis of
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clinical examination such as hepatosplenomegaly
amongst other symptoms. Haematologically their
peripheral blood leukocyte count varied between
150xl091-l to 200x1091-1, with immature
granulocytes in all stages of maturation. The M:E
ratio in bone marrow was between 10 and 30. The
LAP score was <10 in all patients. The patients
were treated with busulfan or hydroxyurea to bring
about clinical and haematological remission, as
defined by regression in spleen and liver sizes,
normal WBC count with no immature granulocytes
in the peripheral blood and <5% blasts in the
bone marrow. The patients were devoid of any
therapy during remission. The first remission
generally lasted for about a year, after which the
patients showed increased WBC count in the
peripheral blood (- 40 x 1091-1) with immature
granulocytes in circulation and slightly enlarged
spleen and liver. They were then given a second
course of chemotherapy. The second remission
usually lasted for a few months only. A total of
36CML patients in either 1st, 2nd or 3rd remission
were used for these studies, along with 18 normal
healthy controls.
Separation ofperipheral blood mononuclear cells
Ten ml of peripheral blood was collected in
preservative free heparin (100I.U. ml-1) and
mononuclear cells were separated on Ficoll-
Hypaque gradient. The cells were washed thrice
with 0.85% saline and suspended at a concentration
of 2x 106 cellsm1-t of RPMI 1640 containing
25mM HEPES, supplemented with 10% FCS
(Difco), 4mM glutamine, 100 Uml-I penicillin and
50 pgml- streptomycin (complete medium). One
aliquot of cells was used for the generation of
suppressor cells, while another sample was stored at
4°C to be used as responders the following day.
Generation ofsuppressor cells
Mononuclear cells at a concentration of 2 x 106
cellsml -1 in complete medium were mixed with
20 pgml- of Con A (Sigma). Equal numbers of
cells were kept as controls without Con A. The
cultures were incubated at 37°C in humidified 5%
CO2 atmosphere for 24h.
Suppressor cell assay
Following incubation, cells with or without Con A
were washed with 0.85% saline containing 0.3Ma-
methylglucoside to remove Con A. These cells were
treated with Mitomycin C (MMC) at a
concentration of 50 pgml - I per 3-5 x 106 cells
suspended in ml of RPMI at 37°C for 30-40min.
The MMC treated cells were washed thrice with
0.85% saline, tested for viability (generally >90%)
and suspended at a concentration of 2 x 106 viable
cellsml'- in complete medium.
Responder cells stored at 4°C were washed twice
with complete medium and suspended in complete
medium adjusting the cell count to 2 x 106 viable
cellsml-'. Quadruplicate cultures were set up in
microtiter plates with 0.1 ml responders, 0.1 ml
regulators (treated with or without Con A) and
10pgml-' of PHA (Difco). The 1:1 ratio of
responders to suppressor was deduced after
ascertaining the maximum suppressor activity of
suppressor cells added at 2:1, 1:1 and 1:2 ratios.
This ratio of responders and suppressors has also
been used by several other investigators (Catalona
et al., 1980; Sakane et al., 1981; Toge et al., 1980;
Uchida & Micksche, 1981). In one set of cultures
responder cells alone were stimulated with PHA to
obtain maximum response. In each set, control
cultures were kept without addition of PHA.
Proliferative response was evaluated after 72h by
addition of 0.5pCi/well of [3H]-dT (Sp. act. 5-
9CimM-', BARC, Trombay, Bombay, India) 16-
18h prior to harvesting. Cultures were processed for
scintillation counting as described earlier (Gangal et
al., 1979). The results are expressed as net cpm
wherein mean cpm of unstimulated cultures is
subtracted from cpm of each stimulated culture.
Percentage suppression was calculated using the
following formula:
% Suppression=100
Net cpm in responders +regulators+PHAt
Net cpm in responders+PHA J
The results were analysed by Student's t test.
Enumeration of autologous rosette forming cells
(ARFC)
Peripheral blood mononuclear cells from CML
patients in remission and normal healthy controls
were separated and incubated with or without Con
A as before. However, for generation of ARFC,
instead of terminating the Con A treatment after
24h, the treatment was continued up to 60h
(Sakane et al., 1981). At the end of the incubation
period, cells were washed with 0.85% saline
containing 0.3 Ma-methyl glucoside to remove Con
A as before. Cell concentration was then adjusted to
2x 106 cells in 0.2ml of RPMI 1640 and 0.3ml of
FCS. To this, 0.5ml of 1% autologous RBCs
suspended in RPMI 1640 were added. For
obtaining autologous RBCs peripheral blood of the
same individual was collected separately in Alsever's
solution on the first day, washed and stored in
Alsever's solution at 4°C. Before use, the RBCs were
washed 5 times with 0.85% saline and suspended in
RPMI 1640. The Con A treated and untreated cellsSUPPRESSOR CELLS IN CML 785
were mixed with autologous RBCs thoroughly,
incubated at 37°C for 20-30min, centrifuged at low
speed and kept at 4°C overnight. The next day, the
pellet was gently shaken, a drop of methylene blue
was added to stain the lymphocytes and a total of
200 lymphocytes (rosetted and nonrosetted) were
counted to enumerate the percentage of ARFC.
Results
Table I describes the data on Con A induced
suppressor cell activity in the peripheral blood
lymphocytes obtained from 9 normal healthy
individuals. Addition of Con A activated regulators
reduced the [3H]-dT uptake in lymphocyte cultures
stimulated with PHA in all the experiments. The
extent of suppression varied from 26.1% to 45.4%
(mean, 36.5%). It can also be seen from Table I that
there was spontaneous generation of suppressor
cells in cultures incubated without Con A, although
the percentage suppression induced spontaneously
in 8/9 cases was much less compared to Con A
treated cells. One individual generated a higher
number of spontaneous suppressor cells, so that the
suppression induced by Con A activated cells was
not significant.
Table II gives the results of Con A induced
suppressor cell activity of peripheral blood
lymphocytes from 11 CML patients in 1st remission.
It is evident that PHA reponses of CML patients in
remission are comparable to normals. The mean
cpm appears to be high because of high reactivity of
patient AN 2009. However, a larger number of
presuppressor cells could be activated by Con A, so
that the percent suppression of PHA response
induced by these cells was much higher in CML
(61.8%) compared to normals (36.5%). Only one
patient (AH 14090) showed lower percentage of
suppression with Con A while percentage of
Table I Con-A induced suppressor cell activity in peripheral blood lymphocytes from
normal healthy individuals.
cpm in lymphocyte cultures
Con-A
treated Control Difference
cells+ Mean % cells+ Mean % between I
Responders responders suppression responders suppression & I*
No. +PHA +PHA I +PHA H (P value)
1 20819 13647 34.5 20475 1.7 <0.001
+2321 + 1846 +2165
2 22198 14201 36.0 16980 23.5 NS
±1760 +322 +1081
3 33786 20422 39.6 28746 15.0 <0.001
+ 1607 +1448 +2944
4 25685 16644 35.2 24401 5.0 <0.001
+1867 + 1372 +1946
5 17027 11578 32.0 16431 3.5 <0.001
+2063 +1266 + 1283
6 24287 13257 45.4 22064 9.2 <0.001
+ 1747 +490 +963
7 26807 16176 39.7 22154 17.4 <0.001
+1288 +517 +3413
8 33677 20145 40.2 29612 12.1 <0.001
+802 + 1801 +262
9 27339 20218 26.1 26302 3.8 <0.001
+1193 +1732 +3758
Mean 25736 16254 36.5+ 1.9 23018 10.1+2.5
+s.e. +1849 +1119 (P<0.001)** +1567
*Individual percent suppression values from I and II compared by Students' t test.
**P value in comparison with mean percent suppression in II.
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Table II Con-A induced suppressor cell activity in peripheral blood lymphocytes from CML
patients in first remission.
cpm in CML lymphocyte cultures
Con-A
treated Control Difference
cells+ Mean % cells+ Mean % between I
Responders responders suppression responders suppression and I*
Case no. +PHA +PHA I +PHA H (P value)
AN 5573 54548 25622 53.0 44869 18.0 <0.001
+3539 +2888 + 1374
AN 1952 42759 8111 81.0 31753 25.7 <0.001
+3429 +497 +1367
AP 3074 53723 11636 78.3 23161 56.0 <0.01
+2551 +402 + 1958
AP 14693 33809 7221 78.6 24290 28.0 <0.001
+1442 +692 +1010
AH 14090 30539 25143 17.6 27754 9.1 NS
+1643 +1399 +3920
AL 11657 20954 12172 41.9 19707 9.0 <0.001
+408 +574 +798
AN 2009 99954 13525 86.4 83676 16.0 <0.001
+5494 +1444 +3045
AL 6467 7874 2335 70.3 ND ND ND
+593 +234
AP 1263 38522 14604 62.1 38632 0 <0.001
+ 1335 +2296 +2308
AN 16907 38298 16477 57.0 28298 26.1 <0.001
+2309 +534 +605
AN 15445 33740 15874 53.0 26315 22.0 <0.001
+1940 +1313 +1011
Mean 41338 13884 61.8 34846 23.3
+s.e. +7102 +2121 +6.1 +5917 +4.7
(P<0.001)**
*Individual percent suppression values from I and II compared by Students t test.
**P value in comparison with mean percent suppression in II.
suppression in all other experiments ranged between
41.9 and 86.4. It is also worth noting that
spontaneous suppression is also higher in CML
patients in 1st remission (23.3%) compared to
controls (10.1%). Patient AH 14090, who showed
less Con A induced suppression, demonstrated no
difference between spontaneous and Con A induced
suppression.
Surprisingly, CML patients in 2nd remission
(Table III) showed suppressor activity similar to
those in the 1st remission. In the 10 cases reported
in Table III, Con A induced suppression varied
between 50.6% and 79.7%. The spontaneous
suppression was also similar to that seen in the
lymphocytes from CML patients in 1st remission
(25.3%). Only 5 CML patients in 3rd remission
could be investigated for induction of suppressor
cell activity (Table IV). Although the Con A
induced suppression was slightly reduced (55.3%), it
appears that the generation of spontaneous
suppressor cells is much lower in CML patients in
3rd remission (14.5%), than the previous groups (1st
and 2nd remissions).
Table V summarises the data on Con A induced
and spontaneous suppressor cell activity as well as
ARFC in CML patients in 1st, 2nd and 3rd
remission in comparison with normal healthy
individuals. As stated earlier, all the remission
patients, irrespective of the progression of the
disease had comparable Con A induced suppressorSUPPRESSOR CELLS IN CML 787
Table III Con-A induced suppressor cell activity in peripheral blood lymphocytes from CML
patients in second remission.
cpm in CML lymphocyte cultures
Con-A
treated Control Difference
cells+ Mean % cells+ Mean % between I
Responders responders suppression responders suppression and H*
Case no. +PHA +PHA I +PHA H (P value)
AM 11660 11478 3580 68.8 12159 -0.1 <0.001
+1123 +647 +196
AN 16907 48099 9782 79.7 26199 45.4 <0.001
+ 1367 +321 +368
AN 17648 33892 12898 62.0 25110 25.9 <0.001
+1034 +194 +852
AN 12882 13987 6190 55.7 12190 12.9 <0.001
+195 +175 +201
AP 9834 27216 12978 52.3 20810 23.5 <0.01
+985 +1286 +1340
AP 6599 31804 14187 55.4 27812 12.6 <0.001
+1160 +700 +1463
AM 11269 38947 14535 62.7 33732 13.4 <0.001
+2748 + 1735 +2653
AN 18202 30812 15220 50.6 24201 21.5 <0.001
+1133 +445 +1220
AP 1263 42026 14419 65.7 30645 27.1 <0.001
+1200 +1246 +476
AN 14719 29635 8053 72.8 16173 45.4 <0.001
+3087 +835 +891
Mean 30790 11184 62.6 22903 25.3
+s.e. +3609 + 1280 +3.0 +2353 +4.2
(P<0.001)**
*Individual percent suppression values from I and II compared by Students' t test.
**P value in comparison with mean percent suppression in II.
cell activity, which was significantly higher than the
controls. Activation of spontaneous suppressor cells
by mere incubation of lymphocytes in in vitro
condition, was also higher in CML patients in 1st
and 2nd remission than controls, while spontaneous
suppression seemed to be reduced in CML patients
in 3rd remission. On the other hand, Con A
induced autorosette forming cells were significantly
higher than controls in CML patients in 1st
remission only, whereas CML patients in 2nd and
3rd remission showed normal percentage of ARFC.
The lack of correlation between ARFC activity and
suppressor cell function in 2nd and 3rd remission
lymphocytes samples however, cannot be firmly
concluded since only a few independent blood
samples have been tested for ARFC. There was no
spontaneous increase in ARFC in normal subjects
or any of the CML remission patients.
Discussion
Presence of suppressor cells in hosts bearing
tumours, capable of inhibiting antitumour immune
responses in vitro has often been demonstrated in
human systems (Broder & Waldmann 1978; Naor
1979; Yu et al., 1977; Hersh et al., 1980; Toge et al.,
1980 and Uchida & Micksche, 1981). In the present
investigation we have tried to evaluate the presence
of precursors of suppressor cells in CML patients in788 R. SOMASUNDARAM et al.
Table IV Con-A induced suppressor cell activity in peripheral blood lymphocytes from CML
patients in third remission.
cpm in lymphocyte cultures
Con-A
treated Control Difference
cells+ Mean % cells+ Mean % between
Responders responders suppression responders suppression I & H*
Case no. +PHA +PHA I +PHA H (P value)
AM 6442 13741 7177 47.8 14138 0 <0.001
+1147 +642 +383
AJ 13455 57130 26504 53.6 49978 12.5 <0.001
+4416 +764 + 1388
AP 15790 36170 10901 69.9 32149 11.1 <0.001
+746 + 1242 +2375
AL 5826 36933 13990 62.1 33329 10.5 <0.001
+2215 + 1866 +2373
AP 5260 28571 16237 43.2 21749 23.9 <0.01
+2610 +968 +571
Mean 34509 14692 55.3+4.8 30269 14.5+3.2
+s.e. +7024 ±3262 (P<0.001)** +6058
*Individual percent suppression values from I and II compared by Students' t test.
**P value in comparison with mean percent suppression in II.
Table V Comparison between Con-A induced suppressor cell activity and autorosette forming cells
(ARFC) in normal individuals and CML patients in remission.
Suppressor cell % suppression Normal CML CML CML
generation and ARFC individuals Ist remission 2nd remission 3rd remission
With Con A 36.5+1.9 61.8+6.1 62.6+3.0 55.3+4.8 %o suppression (n =9) (n=11) (n=10) (n=5)
P value* P<0.001 P<0.001 P<0.01
Without %sprsin 10.1+2.5 23.3+4.7 25.3+4.2 14.5+3.2
Con A % suppression (n=9) (n=9) (n =9) (n=4)
P value* P<0.05 P<0.01 N.S.
With Con A % ARFC 33.5+3.5 53.2+3.1 34.4+4.5 37.6+2.9
%ARFC (n=9) (n= 10) (n=5) (n=3)
P value P<0.001 NS NS
Without % ARFC 4.4+0.4 4.9+0.6 6.4+0.7 5.6+0.8
Con A ° (n=9) (n=10) (n=5) (n=3)
P value* NS NS NS
*As compared to normal healthy individuals.SUPPRESSOR CELLS IN CML 789
remission, which could be activated to carry out
suppressor function by treatment with Con A.
Activation by Con A of peripheral blood
mononuclear cells resulting in cell populations that
can non-specifically suppress the effector functions
of other cells has been amply demonstrated before
(Shou et al., 1976; Tsokos & Balow, 1982; Sakane
& Green 1977; Catalona et al., 1979; Uchida &
Micksche 1981; Shulof et al., 1980; Toge et al.,
1980). Catalona et al (1979) studied activation of
Con A induced suppressor cells from draining
lymph nodes of patients with urological cancers.
Lymph node cells from patients with localized
disease and benign lesions did not generate
suppressor cells following Con A activation, while
patients with metastatic disease did reveal
suppressor cell precursors in the draining lymph
nodes. However, in their subsequent studies
(Catalona et al., 1980) and those of Uchida &
Micksche (1981), increased activation of suppressor
cells by Con A treatment of the peripheral blood
lymphocytes of patients with cancer could not be
demonstrated. Our studies have demonstrated that
CML patients in remission show activation of
suppressor cells by Con A to a significantly greater
extent than that shown by normal healthy donors.
However, we did not find differences in the
suppressor cell activity of Con A treated
lymphocytes in first and subsequent remissions,
indicative of a correlation with progression of the
disease, as suggested by Yu et al. (1977); Catalona
et al. (1979) and Toge et al. (1980). Similarly, our
data also show that most of the CML patients in
remission had normal blastogenic responses to
PHA, yet they showed a significantly increased
generation of suppressor cell population, unlike that
reported by Hersh et al. (1980).
In this study, two patients, viz. AP 1263 and AN
16907 were tested sequentially in 1st and 2nd
remissions. It is interesting to note that AN 16907
showed 57% suppression of PHA response of
autologous lymphocytes in presence of Con A
activated cells in the 1st remission, which was
increased to 79.7% (P<0.001) in the 2nd remission.
Similarly, in the 1st remission he showed
spontaneous suppression to the extent of 26.1%,
which was increased to 45.4% (P<0.001) in the 2nd
remission. Unfortunately, this patient was lost to
follow up thereafter so that progression of his
disease cannot be correlated with these findings. On
the other hand, patient AP 1263 did not show a
difference in Con A induced suppressor cell activity
in 1st and 2nd remission, although he showed
increased spontaneous suppresion in 2nd remission.
This patient continued to be in remission for -8
months, and has now entered into relapse.
In our experiments, spontaneous differentiation of
lymphocytes into functional suppressors, after
incubation in tissue culture media for 24h was seen
in healthy donors as well as in CML patients.
However, a signifiantly higher degree of
spontaneous suppression was seen in lymphocytes
from CML patients than from healthy donors.
Spontaneous generation of suppressor cells has been
shown to occur by other investigators (Burns et al.,
1975; Gattringer et al., 1981; Tsokos & Balow,
1982). It was surprising to note that in our
experiments patients in the 3rd remission, who are
closer to the terminal stage of the disease, showed
spontaneous suppression comparable to normal
donors. From these data it appears that the
presence of a suppressor cell precursor subset of T
cells in the circulation perhaps does not influence
the course of the disease in CML.
The phenomenon of autorosette formation has
not received much attention to date. Our data
suggest that Con A activated cells show increased
autorosette formation, as has been demonstrated by
Sakane et al. (1981, 1982). It appears that CML
patients in 1st remission had significantly higher
ARFC after Con A treatment. However, in a few
patients tested in subsequent remissions, ARFC
seem to be comparable to controls. In an
independent group of CML patients in 2nd and 3rd
remission, functionally suppressive cells could be
demonstrated. This lack of correlation between the
two assays needs to be confirmed in a larger
number of pateints. Spontaneous generation of
ARFC was not demonstrable either in healthy
donors or in CML patients.
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